Ne Guo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Dna Damage Response

Endoplasmic Reticulum Stress

Top Venues

EMBO molecular medicine

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine (2023)
Li-Min Wang, Pingyuan Wang, Xiao-Min Chen, Hui Yang, Shan-Shan Song, Zilan Song, Li Jia, Hua-Dong Chen, Xu-Bin Bao, Ne Guo, Xia-Juan Huan, Yong Xi, Yan-Yan Shen, Xin-Ying Yang, Yi Su, Yi-Ming Sun, Ying-Lei Gao, Yi Chen, Jian Ding, Jing-Yu Lang, Ze-Hong Miao, Ao Zhang, Jin-Xue He
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. EMBO molecular medicine 15 (3) (2023)
Ne Guo, Meng-Zhu Li, Li-Min Wang, Hua-Dong Chen, Shan-Shan Song, Ze-Hong Miao, Jin-Xue He
Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion. Cancer biology & therapy 23 (1) (2022)